Highlights
NASDAQ: JNCE       Jounce Therapeutics Inc
Last Price Today's Change   Day's Range   Trading Volume
5.39   -0.02 (0.37%)  5.16 - 5.80  297,300

Overview

 
Avg Volume (4 weeks):262,331
4 Weeks Range:4.30 - 5.96
4 Weeks Price Volatility (%):
65.66%
52 Weeks Range:2.79 - 10.00
52 Weeks Price Volatility (%):
36.06%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Jounce Therapeutics Inc is a clinical stage immunotherapy company. The company is dedicated to transforming the treatment of cancer by developing therapies that enable the immune system to attack tumors and provide long-lasting benefits to patients. The company's strategy is to create immunotherapies targeting a variety of the diverse cellular components of the immune system, as well as non-immune cells resident within the tumor, all of which can vary greatly among tumors within and across indications. This may provide benefit to patients with tumors across the spectrum from highly inflamed, or hot, to poorly inflamed, or cold, and especially those not well served by current therapies. Its lead product candidate, JTX-2011, is a clinical stage monoclonal antibody.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

4779  3343  551  179 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 GE 6.57-0.21 
 NLY 6.16-0.18 
 SPY 304.32+1.35 
 BAC 24.12-0.74 
 ADAP 11.07+6.21 
 MRO 5.34-0.36 
 F 5.71-0.14 
 XLF 23.41-0.27 
 SQQQ 9.43-0.40 
 NERV 3.71-9.76 
Partners & Brokers